The Science Behind MIEBO® (perfluorohexyloctane ophthalmic solution)

Dry eye disease (DED) is a complex condition that affects millions with uncomfortable symptoms and can impact quality of life. In this episode, Dr. Lievens and Dr. Lyerly discuss the science behind MIEBO a breakthrough treatment indicated for the signs and symptoms of DED that directly targets tear evaporation. Joined by Dr. Jessilin Quint, Dr. Lievens and Dr. Lyerly explore how MIEBO creates a protective monolayer, stabilizing the tear film and providing relief. The conversation also touches on patient success stories, how MIEBO has become a reliable choice for practitioners, and the critical role of educating patients on DED. Key Highlights: • Why MIEBO is an appropriate treatment option for managing evaporative dry eye • Real-world patient outcomes and insights from DED specialists • How MIEBO offers rapid and sustained relief of DED signs and symptoms • Tips for eye care professionals on prescribing MIEBO • If you’re a new or seasoned eye care professional, or simply want to learn about the latest in dry eye management, this episode is packed with valuable insights. INDICATION MIEBO® (perfluorohexyloctane ophthalmic solution) is indicated for the treatment of the signs and symptoms of dry eye disease. IMPORTANT SAFETY INFORMATION • MIEBO is contraindicated in patients with known hypersensitivity to perfluorohexyloctane • MIEBO should not be administered while wearing contact lenses. Contact lenses should be removed before use and for at least 30 minutes after administration of MIEBO • Instruct patients to instill one drop of MIEBO into each eye four times daily • The safety and efficacy in pediatric patients below the age of 18 have not been established • In pivotal trials, the most common ocular adverse reaction was blurred vision (1% to 3% of patients reported blurred vision and conjunctival redness) Please see full Prescribing Information for MIEBO at MIEBO-ECP.COM. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088. -------------------------- Let’s Connect! Defocus Media on Social Media: 👁️ Instagram:   / defocusmedia   👁️ Facebook:   / defocusmedia   👁️ LinkedIn:   / defocus-media   👁️ Twitter:   / defocusmedia   👀 Website: https://defocusmediagroup.com/ 👀 Want to stay up to date on the latest trends and hottest topics in eye care? 📧 Sign up for our newsletter! https://share.hsforms.com/1rhZdAHr_Ss... -------------------------- DISCLAIMER: All content in this video and description, including infor­ma­tion, opinions, con­tent, ref­er­ences, and links, is for infor­ma­tional pur­poses only. The Author does not pro­vide any med­ical advice on the site. Noth­ing con­tained in this video or its description is intended to estab­lish a physician-patient rela­tion­ship, to replace the ser­vices of a trained physi­cian or health care pro­fes­sional, or oth­er­wise to be a sub­sti­tute for pro­fes­sional med­ical advice, diag­no­sis, or treatment. You should con­sult a licensed physi­cian or appropriately credentialed health care worker in your com­mu­nity in all mat­ters relat­ing to your health. Also, some of the links in this post may be affiliate links, meaning, at no cost to you, I will earn a small commission if you click through and make a purchase. All non-licensed clips are used for fair use commentary, criticism, and educational purposes.

Evaporative Dry Eye Relief With MIEBO® (perfluorohexyloctane ophthalmic solution)
▶︎

Evaporative Dry Eye Relief With MIEBO® (perfluorohexyloctane ophthalmic solution)

Top Dry Eye Treatments Ranked!
▶︎

Top Dry Eye Treatments Ranked!

Body Language Expert: Stop Using This, It’s Making People Dislike You, So Are These Subtle Mistakes!
▶︎

Body Language Expert: Stop Using This, It’s Making People Dislike You, So Are These Subtle Mistakes!

Why You Can’t Sleep (and How to Fix It) |  Dr. Michael Grandner
▶︎

Why You Can’t Sleep (and How to Fix It) | Dr. Michael Grandner

Medical breakthroughs and health stories | 60 Minutes Marathon
▶︎

Medical breakthroughs and health stories | 60 Minutes Marathon

SMC Webinar Series - Part 3: Converting to a Sale - Turning hesitation into commitment
▶︎

SMC Webinar Series - Part 3: Converting to a Sale - Turning hesitation into commitment

Graham Plattner LIVE: 'MAINE VOTERS REGRET' Makes His Case Against Susan Collins In Fiery Speech
▶︎

Graham Plattner LIVE: 'MAINE VOTERS REGRET' Makes His Case Against Susan Collins In Fiery Speech

But what is quantum computing?  (Grover's Algorithm)
▶︎

But what is quantum computing? (Grover's Algorithm)

What do tech pioneers think about the AI revolution? - The Engineers, BBC World Service
▶︎

What do tech pioneers think about the AI revolution? - The Engineers, BBC World Service

How to Invest As a Teen With $0
▶︎

How to Invest As a Teen With $0

How Proctor’s texts in Karen Read lawsuit could free dangerous criminals
▶︎

How Proctor’s texts in Karen Read lawsuit could free dangerous criminals

Xiidra® (lifitegrast ophthalmic solution) 5%: Understanding Inflammation in Dry Eye
▶︎

Xiidra® (lifitegrast ophthalmic solution) 5%: Understanding Inflammation in Dry Eye

ABC MCI Webinar Series Session 2: Managing MCI: Clinical and Community Perspectives
▶︎

ABC MCI Webinar Series Session 2: Managing MCI: Clinical and Community Perspectives

The Most Famous (TV) Doctor Of All Time | Noah Wyle
▶︎

The Most Famous (TV) Doctor Of All Time | Noah Wyle

AI 최후의 승자 이래서 구글입니다 (KAIST 전자및전기공학부 김정호 교수)
▶︎

AI 최후의 승자 이래서 구글입니다 (KAIST 전자및전기공학부 김정호 교수)

System Design Course – APIs, Databases, Caching, CDNs, Load Balancing & Production Infra
▶︎

System Design Course – APIs, Databases, Caching, CDNs, Load Balancing & Production Infra

Will Australia's social media ban for under-16s work? - The Global Story podcast, BBC World Service
▶︎

Will Australia's social media ban for under-16s work? - The Global Story podcast, BBC World Service

How AI Cracked the Protein Folding Code and Won a Nobel Prize
▶︎

How AI Cracked the Protein Folding Code and Won a Nobel Prize

Lawfare Live: The Trials of the Trump Administration, June 22
▶︎

Lawfare Live: The Trials of the Trump Administration, June 22

India Economy OK…But Danger Ahead? 5-State Polls में NDA 2-0 Lead? • Sriram Seshadri
▶︎

India Economy OK…But Danger Ahead? 5-State Polls में NDA 2-0 Lead? • Sriram Seshadri